IT201700084683A1 - Composizione per la prevenzione ed il trattamento dell’osteopenia - Google Patents

Composizione per la prevenzione ed il trattamento dell’osteopenia

Info

Publication number
IT201700084683A1
IT201700084683A1 IT102017000084683A IT201700084683A IT201700084683A1 IT 201700084683 A1 IT201700084683 A1 IT 201700084683A1 IT 102017000084683 A IT102017000084683 A IT 102017000084683A IT 201700084683 A IT201700084683 A IT 201700084683A IT 201700084683 A1 IT201700084683 A1 IT 201700084683A1
Authority
IT
Italy
Prior art keywords
osteopenia
prevention
treatment
composition
Prior art date
Application number
IT102017000084683A
Other languages
English (en)
Inventor
Carolina Eigenmann
Original Assignee
Sochim Int S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sochim Int S P A filed Critical Sochim Int S P A
Priority to IT102017000084683A priority Critical patent/IT201700084683A1/it
Priority to PCT/IB2018/055483 priority patent/WO2019021163A1/en
Priority to EP18753249.4A priority patent/EP3658175B1/en
Publication of IT201700084683A1 publication Critical patent/IT201700084683A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102017000084683A 2017-07-25 2017-07-25 Composizione per la prevenzione ed il trattamento dell’osteopenia IT201700084683A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102017000084683A IT201700084683A1 (it) 2017-07-25 2017-07-25 Composizione per la prevenzione ed il trattamento dell’osteopenia
PCT/IB2018/055483 WO2019021163A1 (en) 2017-07-25 2018-07-24 COMPOSITION FOR THE PREVENTION AND TREATMENT OF OSTEOPENIA
EP18753249.4A EP3658175B1 (en) 2017-07-25 2018-07-24 Composition for the prevention and treatment of osteopenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000084683A IT201700084683A1 (it) 2017-07-25 2017-07-25 Composizione per la prevenzione ed il trattamento dell’osteopenia

Publications (1)

Publication Number Publication Date
IT201700084683A1 true IT201700084683A1 (it) 2019-01-25

Family

ID=60451059

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000084683A IT201700084683A1 (it) 2017-07-25 2017-07-25 Composizione per la prevenzione ed il trattamento dell’osteopenia

Country Status (3)

Country Link
EP (1) EP3658175B1 (it)
IT (1) IT201700084683A1 (it)
WO (1) WO2019021163A1 (it)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005068060A (ja) * 2003-08-22 2005-03-17 Nrl Pharma Inc ラクトフェリンを含有する医薬組成物ならびに加工食品の製造法
JP2006083151A (ja) * 2004-09-16 2006-03-30 Oriza Yuka Kk 骨粗鬆症予防、改善用組成物
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2008009798A1 (fr) * 2006-07-19 2008-01-24 Bio Serae Laboratoires Sa Composition a base de d-glucosamine, de lactoferrine et de chondroitine sulfate pour prevenir et/ou pour traiter les maladies articulaires dégénératives
CN101156630A (zh) * 2007-11-16 2008-04-09 中国农业大学 骨关节强化奶
WO2011074992A1 (en) * 2009-12-15 2011-06-23 Dec International Nz Limited Treatment composition and method
US20150174218A1 (en) * 2006-04-28 2015-06-25 Naidu Lp ANGIOGENIN COMPLEXES (ANGex) WITH ANABOLIC HORMONES FOR IMPROVING BONE HEALTH

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005068060A (ja) * 2003-08-22 2005-03-17 Nrl Pharma Inc ラクトフェリンを含有する医薬組成物ならびに加工食品の製造法
JP2006083151A (ja) * 2004-09-16 2006-03-30 Oriza Yuka Kk 骨粗鬆症予防、改善用組成物
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
US20150174218A1 (en) * 2006-04-28 2015-06-25 Naidu Lp ANGIOGENIN COMPLEXES (ANGex) WITH ANABOLIC HORMONES FOR IMPROVING BONE HEALTH
WO2008009798A1 (fr) * 2006-07-19 2008-01-24 Bio Serae Laboratoires Sa Composition a base de d-glucosamine, de lactoferrine et de chondroitine sulfate pour prevenir et/ou pour traiter les maladies articulaires dégénératives
CN101156630A (zh) * 2007-11-16 2008-04-09 中国农业大学 骨关节强化奶
WO2011074992A1 (en) * 2009-12-15 2011-06-23 Dec International Nz Limited Treatment composition and method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CORNISH J ET AL: "Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo", ENDOCRINOLOGY, THE ENDOCRINE SOCIETY, US, vol. 145, no. 9, 1 January 2004 (2004-01-01), pages 4366 - 4374, XP003011980, ISSN: 0013-7227, DOI: 10.1210/EN.2003-1307 *
H. Y. GUO ET AL: "Orally Administered Lactoferrin Preserves Bone Mass and Microarchitecture in Ovariectomized Rats", THE JOURNAL OF NUTRITION, vol. 139, no. 5, 25 March 2009 (2009-03-25), pages 958 - 964, XP055183550, ISSN: 0022-3166, DOI: 10.3945/jn.108.100586 *
LANHAM-NEW SUSAN A: "Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment", PROCEEDINGS OF THE NUTRITION SOCIETY, LONDON, GB, vol. 67, 1 May 2008 (2008-05-01), pages 163 - 176, XP002573405, ISSN: 0029-6651, [retrieved on 20080415], DOI: 10.1017/S0029665108007003 *

Also Published As

Publication number Publication date
EP3658175A1 (en) 2020-06-03
EP3658175B1 (en) 2023-04-05
WO2019021163A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
DK3565550T3 (da) Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
IL259861A (en) Methods and preparations for the treatment of disorders related to seizures
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3328864T3 (da) Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser
DK3271015T3 (da) Nk-3-receptorantagonister til terapeutisk eller kosmetisk behandling af overskydende kropsfedt
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
ES2970485T3 (es) Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
IL264977A (en) Methods and preparations for the treatment of melanoma
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700111261A1 (it) Composizione per il trattamento delle neuropatie metaboliche e meccaniche
GB201702603D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ITUA20163025A1 (it) Composizione per il trattamento della sindrome dell’ovaio policistico
IT201700084683A1 (it) Composizione per la prevenzione ed il trattamento dell’osteopenia
IT201700032960A1 (it) Composto nutraceutico per il trattamento dell’eccesso di peso e della moderata ipercolesterolemia e disglicemia
MA47768A (fr) Dosage et régime thérapeutiques pour la mélatonine
IT201600109507A1 (it) Composizione per il trattamento preventivo o curativo dei disturbi epatici
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
ITUB20160863A1 (it) Metodo per la diagnosi e la tipizzazione dell’amiloidosi
ITUB20160141A1 (it) Composizione per la prevenzione ed il trattamento di cefalee primarie
IT201700083444A1 (it) Composizione per la prevenzione e/o il trattamento di patologie tiroidee